Pleiotrophin/Osteoblast-Stimulating Factor 1: Dissecting Its Diverse Functions in Bone Formation
- 1 November 2002
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 17 (11), 2009-2020
- https://doi.org/10.1359/jbmr.2002.17.11.2009
Abstract
OSF-1, more commonly known as pleiotrophin (PTN) or heparin-binding growth-associated molecule (HB-GAM), belongs to a new family of secreted HB proteins, which are structurally unrelated to any other growth factor family. The aims of this study were to dissect the diverse functions of PTN in bone formation. The study showed that PTN was synthesized by osteoblasts at an early stage of osteogenic differentiation and was present at sites of new bone formation, where PTN was stored in the new bone matrix. Low concentrations (10 pg/ml) of PTN stimulated osteogenic differentiation of mouse bone marrow cells and had a modest effect on their proliferation, whereas higher concentrations (ng/ml) had no effect. However, PTN did not have the osteoinductive potential of bone morphogenetic proteins (BMPs) because it failed to convert C2C12 cells, a premyoblastic cell line, to the osteogenic phenotype, whereas recombinant human BMP-2 (rhBMP-2) was able to do so. When PTN was present together with rhBMP-2 during the osteoinductive phase, PTN inhibited the BMP-mediated osteoinduction in C2C12 cells at concentrations between 0.05 pg/ml and 100 ng/ml. However, when added after osteoinduction had been achieved, PTN enhanced further osteogenic differentiation. An unusual effect of PTN (50 ng/ml) was the induction of type I collagen synthesis by chondrocytes in organ cultures of chick nasal cartilage and rat growth plates. Thus, PTN had multiple effects on bone formation and the effects were dependent on the concentration of PTN and the timing of its presence. To explain these multiple effects, we propose that PTN is an accessory signaling molecule, which is involved in a variety of processes in bone formation. PTN enhances or inhibits primary responses depending on the prevailing concentrations, the primary stimulus, and the availability of appropriate receptors.Keywords
This publication has 81 references indexed in Scilit:
- A Role for the BMP Antagonist Chordin in Endochondral OssificationJournal of Bone and Mineral Research, 2002
- Heparin-binding Growth-associated Molecule Contains Two Heparin-binding β-Sheet Domains That Are Homologous to the Thrombospondin Type I RepeatPublished by Elsevier BV ,2000
- Expression of Bone Morphogenetic Protein-2 via Adenoviral Vector in C2C12 Myoblasts Induces Differentiation into the Osteoblast LineageBiochemical and Biophysical Research Communications, 1999
- Bone Mass Loss Due to Estrogen Deficiency Is Compensated in Transgenic Mice Overexpressing Human Osteoblast Stimulating Factor-1Biochemical and Biophysical Research Communications, 1997
- Effects of a bone lysine-rich 18 kDa protein on osteoblast-like MC3T3-E1 cellsBiochemical and Biophysical Research Communications, 1992
- Hypertrophic chondrocytes undergo further differentiation in cultureThe Journal of cell biology, 1992
- Immunohistochemical localization of bone sialoprotein in foetal porcine bone tissues: comparisons with secreted phosphoprotein 1 (SPP-1, osteopontin) and SPARC (osteonectin)Journal of Molecular Histology, 1991
- Molecular cloning of RI-HB, a heparin binding protein regulated by retinoic acidBiochemical and Biophysical Research Communications, 1991
- Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissuesBiochemical and Biophysical Research Communications, 1990
- A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: Purification and N-terminal amino acid sequenceBiochemical and Biophysical Research Communications, 1989